In a crucial turn of events, the Trump administration has lifted its freeze on nearly $20 million for HIV prevention programs following significant public outcry. This funding is vital for combating new infections and supporting the LGBTQ+ community.
Today marks the Supreme Court's final day, with critical rulings on birthright citizenship and other significant cases. Plus, insights into the changing CDC under Robert F. Kennedy Jr. and the effectiveness of Zohran Mamdani's social media campaign.
In a surprising move, federal vaccine advisers have voted to remove thimerosal from flu shots, aligning with anti-vaccine activists. This decision raises concerns about vaccine availability and public health.
A new monoclonal antibody called clesrovimab has been recommended for infants to prevent RSV, stirring debate among health experts and advocates. The FDA approved the treatment just weeks ago.
In a pivotal vote, the CDC's advisory committee has recommended the use of clesrovimab, a new monoclonal antibody, for infants under eight months to combat RSV, marking a significant advancement in public health.
A child in Greensboro tested positive for measles, prompting North Carolina hospitals to prepare for potential outbreaks. Experts warn of low vaccination rates and the contagious nature of the virus.
Explore the century-long debate surrounding thimerosal in vaccines, its alleged link to autism, and the latest CDC discussions that have experts on edge. Are vaccines truly safe?
In a startling announcement, the Wayne County Health Department confirmed Illinois' first human case of West Nile Virus in 2025. A resident was hospitalized but is now recovering at home. The CDC warns about the dangers of mosquito bites.
A CDC presentation by Lyn Redwood claims a non-existent study links thimerosal to brain damage, raising alarms about vaccine misinformation. Experts question the credibility of new vaccine advisers.
In a surprising turn of events, Dr. Michael Ross has withdrawn from the vaccine advisory panel after a conflict of interest review revealed ties to private healthcare companies. This comes amidst ongoing scrutiny of the committee’s integrity.
